# MiMedx Group, Inc. – FDA Inspection, Dec 12, 2019

Source: https://www.keypedia.com/records/fda_inspections/mimedx-group-inc/1435ccd2-4ab5-4cff-850f-38e6beb19f63
Source feed: FDA_Inspections

> FDA inspection 1112843 of MiMedx Group, Inc., December 12, 2019. Classification: Voluntary Action Indicated (VAI). 14 citations under 21 CFR parts 211 and 1271. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1112843
- Company Name: MiMedx Group, Inc.
- Inspection Date: 2019-12-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 14

## Related Documents

- [FDA Inspection 1198732 - 2023-03-02](https://www.keypedia.com/records/fda_inspections/mimedx-group-inc/495a9599-303b-4b00-9b51-d82febc2ac7a)
- FDA Inspection 1069242 - 2018-09-26

Company: https://www.keypedia.com/companies/mimedx-group-inc/48cc856a-f21d-4488-bbbd-4428f7bf1308

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
